These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15473417)

  • 1. A critique on contemporary reporting of likelihood ratios in test power analysis.
    Weissler AM; Bailey KR
    Mayo Clin Proc; 2004 Oct; 79(10):1317-8. PubMed ID: 15473417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic likelihood ratios].
    Capron L
    Rev Prat; 2000 Nov; 50(17):1865-9. PubMed ID: 11151325
    [No Abstract]   [Full Text] [Related]  

  • 3. Number needed to misdiagnose: a measure of diagnostic test effectiveness.
    Habibzadeh F; Yadollahie M
    Epidemiology; 2013 Jan; 24(1):170. PubMed ID: 23232619
    [No Abstract]   [Full Text] [Related]  

  • 4. The diagnostic utility of multiple-level likelihood ratios.
    Bowden SC; Loring DW
    J Int Neuropsychol Soc; 2009 Sep; 15(5):769-76. PubMed ID: 19635177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the gain in diagnostic performance when combining two diagnostic tests.
    Macaskill P; Walter SD; Irwig L; Franco EL
    Stat Med; 2002 Sep; 21(17):2527-46. PubMed ID: 12205697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A perspective on standardizing the predictive power of noninvasive cardiovascular tests by likelihood ratio computation: 1. Mathematical principles.
    Weissler AM
    Mayo Clin Proc; 1999 Nov; 74(11):1061-71. PubMed ID: 10560593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Likelihood ratios, sensitivity, and specificity values can be back-calculated when the odds ratios are known.
    Simel DL; Easter J; Tomlinson G
    J Clin Epidemiol; 2013 Apr; 66(4):458-60. PubMed ID: 23021858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to evaluate a diagnostic test.
    Eckert SE; Goldstein GR; Koka S
    J Prosthet Dent; 2000 Apr; 83(4):386-91. PubMed ID: 10756286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregation across multiple indicators improves the detection of malingering: relationship to likelihood ratios.
    Larrabee GJ
    Clin Neuropsychol; 2008 Jul; 22(4):666-79. PubMed ID: 17886147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of a rapid diagnostic screen (URISCREEN) for bacteriuria in children.
    Palmer LS; Richards I; Kaplan WE
    J Urol; 1997 Feb; 157(2):654-7. PubMed ID: 8996393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis.
    Lyman GH; Kuderer NM
    Clin Breast Cancer; 2006 Dec; 7(5):372-9. PubMed ID: 17239261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of diagnostic tests.
    Gjørup T
    Acta Obstet Gynecol Scand Suppl; 1997; 166():9-14. PubMed ID: 9253371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of diagnostic or screening procedures. Validity of tests, sensitivity, specificity, predictive values. Definition and indications for mass screening].
    Durand-Zaleski I; Bastuji-Garin S
    Rev Prat; 2000 May; 50(10):1155-8. PubMed ID: 10905104
    [No Abstract]   [Full Text] [Related]  

  • 14. Computers in paediatrics. 18. Medical decision making: computer program to calculate sensitivity, specificity, false positive and negative rates, positive and negative predictive values and accuracy of a diagnostic test.
    Yip WC; Tay JS; Ho TF; Wong HB
    J Singapore Paediatr Soc; 1986; 28(1-2):74-8. PubMed ID: 3531721
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies about diagnostic tests: interpreting the results].
    Salech F; Mery V; Larrondo F; Rada G
    Rev Med Chil; 2008 Sep; 136(9):1203-8. PubMed ID: 19030668
    [No Abstract]   [Full Text] [Related]  

  • 16. External quality assurance for the laboratory diagnosis of Buruli ulcer disease in Ghana.
    Bretzel G; Siegmund V; Nitschke J; Herbinger KH; Thompson R; Fleischmann E; Fleischer B; Adjei O
    Trop Med Int Health; 2006 Nov; 11(11):1688-93. PubMed ID: 17054748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The validity of screening for open-angle glaucoma in high-risk populations with single-test screening mode frequency doubling technology perimetry (FDT).
    Kamdeu Fansi AA; Li G; Harasymowycz PJ
    J Glaucoma; 2011 Mar; 20(3):167-71. PubMed ID: 20436361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior elevation in keratoconus.
    Khachikian SS; Belin MW
    Ophthalmology; 2009 Apr; 116(4):816, 816.e1; author reply 816-7. PubMed ID: 19344833
    [No Abstract]   [Full Text] [Related]  

  • 19. Cataract and glaucoma case detection for Vision 2020 programs in Africa: an evaluation of 6 possible screening tests.
    Cook C; Cockburn N; van der Merwe J; Ehrlich R
    J Glaucoma; 2009 Sep; 18(7):557-62. PubMed ID: 19745671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for disease: making evidence-based choices.
    Fields MM; Chevlen E
    Clin J Oncol Nurs; 2006 Feb; 10(1):73-6. PubMed ID: 16482730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.